FDA Approved: MIRTAZAPINE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Mirtazapine by Prasco Laboratories, enabling a generic version of the antidepressant to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)